160 related articles for article (PubMed ID: 17927494)
1. Elevated tumor necrosis factor-alpha suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma.
Li B; Shi M; Li J; Zhang H; Chen B; Chen L; Gao W; Giuliani N; Zhao RC
Stem Cells Dev; 2007 Dec; 16(6):921-30. PubMed ID: 17927494
[TBL] [Abstract][Full Text] [Related]
2. [The effect of TNF-alpha on TAZ expression and osteogenic potential of mesenchymal stem cells from myeloma patients].
Li BZ; Shi MX; Li J; Ma J; Chen L; Chen B; Zhao CH
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):5-9. PubMed ID: 19538860
[TBL] [Abstract][Full Text] [Related]
3. Wnt and BMP signaling pathways co-operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2.
Wei XF; Chen QL; Fu Y; Zhang QK
J Cell Biochem; 2019 Apr; 120(4):6515-6527. PubMed ID: 30450775
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression.
Cho HH; Shin KK; Kim YJ; Song JS; Kim JM; Bae YC; Kim CD; Jung JS
J Cell Physiol; 2010 Apr; 223(1):168-77. PubMed ID: 20049872
[TBL] [Abstract][Full Text] [Related]
5. The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro: defining the stromal defect in myeloma.
Kassen D; Moore S; Percy L; Herledan G; Bounds D; Rodriguez-Justo M; Croucher P; Yong K
Br J Haematol; 2014 Oct; 167(2):194-206. PubMed ID: 25079197
[TBL] [Abstract][Full Text] [Related]
6. PKD1 alleviates oxidative stress-inhibited osteogenesis of rat bone marrow-derived mesenchymal stem cells through TAZ activation.
Chen T; Wang H; Jiang C; Lu Y
J Cell Biochem; 2021 Nov; 122(11):1715-1725. PubMed ID: 34407229
[TBL] [Abstract][Full Text] [Related]
7. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
8. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
[TBL] [Abstract][Full Text] [Related]
9. IGF1 promotes osteogenic differentiation of mesenchymal stem cells derived from rat bone marrow by increasing TAZ expression.
Xue P; Wu X; Zhou L; Ma H; Wang Y; Liu Y; Ma J; Li Y
Biochem Biophys Res Commun; 2013 Apr; 433(2):226-31. PubMed ID: 23473758
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease.
Zhang L; Lei Q; Wang H; Xu C; Liu T; Kong F; Yang C; Yan G; Sun L; Zhao A; Chen W; Hu Y; Xie H; Cao Y; Fu F; Yuan G; Chen Z; Guo AY; Li Q
Theranostics; 2019; 9(1):196-209. PubMed ID: 30662562
[No Abstract] [Full Text] [Related]
11. Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.
Reagan MR; Mishima Y; Glavey SV; Zhang Y; Manier S; Lu ZN; Memarzadeh M; Zhang Y; Sacco A; Aljawai Y; Shi J; Tai YT; Ready JE; Kaplan DL; Roccaro AM; Ghobrial IM
Blood; 2014 Nov; 124(22):3250-9. PubMed ID: 25205118
[TBL] [Abstract][Full Text] [Related]
12. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
Lu Z; Wang G; Dunstan CR; Zreiqat H
Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
Tsukamoto S; Løvendorf MB; Park J; Salem KZ; Reagan MR; Manier S; Zavidij O; Rahmat M; Huynh D; Takagi S; Kawano Y; Kokubun K; Thrue CA; Nagano K; Petri A; Roccaro AM; Capelletti M; Baron R; Kauppinen S; Ghobrial IM
Leukemia; 2018 Aug; 32(8):1739-1750. PubMed ID: 29925904
[TBL] [Abstract][Full Text] [Related]
14. Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
Giuliani N; Colla S; Morandi F; Lazzaretti M; Sala R; Bonomini S; Grano M; Colucci S; Svaldi M; Rizzoli V
Blood; 2005 Oct; 106(7):2472-83. PubMed ID: 15933061
[TBL] [Abstract][Full Text] [Related]
15. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation.
Hong JH; Hwang ES; McManus MT; Amsterdam A; Tian Y; Kalmukova R; Mueller E; Benjamin T; Spiegelman BM; Sharp PA; Hopkins N; Yaffe MB
Science; 2005 Aug; 309(5737):1074-8. PubMed ID: 16099986
[TBL] [Abstract][Full Text] [Related]
16. TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol.
Byun MR; Jeong H; Bae SJ; Kim AR; Hwang ES; Hong JH
Bone; 2012 Jan; 50(1):364-72. PubMed ID: 22108137
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets.
Giuliani N; Mangoni M; Rizzoli V
Exp Hematol; 2009 Aug; 37(8):879-86. PubMed ID: 19446662
[TBL] [Abstract][Full Text] [Related]
18. The Effects of TNF-α on Osteogenic Differentiation of Umbilical Cord Derived Mesenchymal Stem Cells.
Marupanthorn K; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P; Manochantr S
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S34-40. PubMed ID: 26387386
[TBL] [Abstract][Full Text] [Related]
19. Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes.
Komatsu N; Kajiya M; Motoike S; Takewaki M; Horikoshi S; Iwata T; Ouhara K; Takeda K; Matsuda S; Fujita T; Kurihara H
Stem Cell Res Ther; 2018 Dec; 9(1):342. PubMed ID: 30526677
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activation of TAZ enhances osteogenic differentiation and bone formation of adipose-derived stem cells.
Zhu Y; Wu Y; Cheng J; Wang Q; Li Z; Wang Y; Wang D; Wang H; Zhang W; Ye J; Jiang H; Wang L
Stem Cell Res Ther; 2018 Mar; 9(1):53. PubMed ID: 29514703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
